Cargando…
mRNA vaccines: the most recent clinical applications of synthetic mRNA
Synthetic mRNA has been considered as an emerging biotherapeutic agent for the past decades. Recently, the SARS-CoV-2 pandemic has led to the first clinical use of synthetic mRNA. mRNA vaccines showed far surpassing influences on the public as compared to other vaccine platforms such as viral vector...
Autores principales: | Kwon, Suji, Kwon, Minseon, Im, Seongeun, Lee, Kyuri, Lee, Hyukjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pharmaceutical Society of Korea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012156/ https://www.ncbi.nlm.nih.gov/pubmed/35426547 http://dx.doi.org/10.1007/s12272-022-01381-7 |
Ejemplares similares
-
Development of mRNA Vaccines/Therapeutics and Their Delivery System
por: Son, Sora, et al.
Publicado: (2023) -
Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022) -
Recent Advancement in mRNA Vaccine Development and Applications
por: Al Fayez, Nojoud, et al.
Publicado: (2023) -
Novel piperazine‐based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety
por: Kim, Minjeong, et al.
Publicado: (2023) -
Synthetic mRNA capping
por: Muttach, Fabian, et al.
Publicado: (2017)